TY - JOUR
T1 - Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation
AU - Hansen, J
AU - Nielsen, Anders Rinnov
AU - Krogh-Madsen, R
AU - Fischer, C P
AU - Andreasen, A S
AU - Berg, R M G
AU - Møller, K
AU - Pedersen, B K
AU - Plomgaard, P
N1 - Author Information
1The Centre of Inflammation and Metabolism, Department of Infectious Diseases and CMRC, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
2Neurointensive Care Unit, Department of Neuroanaesthesiology, Rigshospitalet, Copenhagen, Denmark
3Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
* Correspondence to: Jakob Hansen, Rigshospitalet, Centre of Inflammation and Metabolism (CIM), 7641, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
E-mail: [email protected]
PY - 2013/9
Y1 - 2013/9
N2 - Plasma follistatin is elevated in patients with low-grade inflammation and insulin resistance as observed with polycystic ovary syndrome. In the present study, we evaluated plasma follistatin in patients with type 2 diabetes characterised by low-grade inflammation and assessed the acute effects of hyperglycemia, hyperinsulinemia and LPS on plasma follistatin.
AB - Plasma follistatin is elevated in patients with low-grade inflammation and insulin resistance as observed with polycystic ovary syndrome. In the present study, we evaluated plasma follistatin in patients with type 2 diabetes characterised by low-grade inflammation and assessed the acute effects of hyperglycemia, hyperinsulinemia and LPS on plasma follistatin.
U2 - 10.1002/dmrr.2415
DO - 10.1002/dmrr.2415
M3 - Journal article
C2 - 23564759
SN - 1520-7552
VL - 29
SP - 463
EP - 472
JO - Diabetes - Metabolism: Research and Reviews (Print Edition)
JF - Diabetes - Metabolism: Research and Reviews (Print Edition)
IS - 6
ER -